Page last updated: 2024-08-23

spiradoline and mr 2266

spiradoline has been researched along with mr 2266 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohno, M; Ueki, S; Yamamoto, T1
Shimada, Y; Yamada, K; Yoshida, S1
Hamon, G; Jouquey, S1
Nakano, M; Yamada, K; Yoshida, S1
Imai, M; Yamada, K; Yoshida, S1
Shibata, S; Tominaga, K; Watanabe, S1

Reviews

1 review(s) available for spiradoline and mr 2266

ArticleYear
Kappa agonists and vasopressin secretion.
    Hormone research, 1990, Volume: 34, Issue:3-4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Diuretics; Paraventricular Hypothalamic Nucleus; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Supraoptic Nucleus; Vasopressins

1990

Other Studies

5 other study(ies) available for spiradoline and mr 2266

ArticleYear
Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.
    Psychopharmacology, 1992, Volume: 106, Issue:1

    Topics: Analgesics; Animals; Benzomorphans; Cues; Discrimination, Psychological; Dopamine; Dopamine Antagonists; Dynorphins; Male; Morphine; Narcotic Antagonists; Peptide Fragments; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu

1992
Atrial natriuretic polypeptide secretion via selective activation of kappa-opioid receptor: role of dynorphin.
    The American journal of physiology, 1991, Volume: 261, Issue:3 Pt 1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Atrial Natriuretic Factor; Benzomorphans; Cells, Cultured; Diuretics; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Enkephalins; Heart; Heart Atria; Kinetics; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa

1991
Inhibition of elevated arginine vasopressin secretion in response to osmotic stimulation and acute haemorrhage by U-62066E, a kappa-opioid receptor agonist.
    British journal of pharmacology, 1990, Volume: 99, Issue:2

    Topics: Acute Disease; Analgesics; Animals; Arginine Vasopressin; Benzomorphans; Blood Pressure; Dose-Response Relationship, Drug; Hemorrhage; Hypertonic Solutions; Iodine Radioisotopes; Medulla Oblongata; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa

1990
Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist.
    European journal of pharmacology, 1989, Jan-31, Volume: 160, Issue:2

    Topics: Animals; Arginine Vasopressin; Benzomorphans; Diuretics; In Vitro Techniques; Kidney Tubules, Collecting; Male; Narcotic Antagonists; Natriuresis; Osmolar Concentration; Pyrrolidines; Rats; Rats, Inbred BB; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa

1989
kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats.
    European journal of pharmacology, 1995, Jun-12, Volume: 279, Issue:2-3

    Topics: Analgesics; Analgesics, Opioid; Animals; Benzomorphans; Brain Ischemia; Deoxyglucose; Drug Tolerance; Hippocampus; Hypoglycemia; Hypoxia, Brain; In Vitro Techniques; Male; Morphine; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa

1995